A Feasibility Trial of Tamoxifen Chemoprevention of Breast Cancer in Great Britain
Authors:
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 6 (5) , 621-624
Abstract
(1988). A Feasibility Trial of Tamoxifen Chemoprevention of Breast Cancer in Great Britain. Cancer Investigation: Vol. 6, No. 5, pp. 621-624. doi: 10.3109/07357908809082130Keywords
This publication has 10 references indexed in Scilit:
- TAMOXIFEN AND BENIGN BREAST PROBLEMSThe Lancet, 1987
- Endocrine Prevention of Breast Cancer by Tamoxifen1987
- Oral contraceptives and hepatocellular carcinoma.BMJ, 1986
- Oral contraceptives and hepatocellular carcinomaBMJ, 1986
- DOUBLE-BLIND CONTROLLED TRIAL OF TAMOXIFEN THERAPY FOR MASTALGIAThe Lancet, 1986
- THE PREVENTION OF BREAST CANCERThe Lancet, 1986
- Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifenAtherosclerosis, 1984
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981
- INCREASES IN STEROID BINDING GLOBULINS INDUCED BY TAMOXIFEN IN PATIENTS WITH CARCINOMA OF THE BREASTJournal of Endocrinology, 1978
- Long-term reproducibility of bone mineral content measurementsScandinavian Journal of Clinical and Laboratory Investigation, 1977